Insider · CIK 0001365343

Nader Francois

Reports to the SEC for 10 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001365343

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-06	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,454 sh	—	—	6,454
2026-05-06	MRNAModerna, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,185 sh	—	—	4,185
2026-04-30	MRNAModerna, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.2K sh	—	—	32,781
2026-04-30	MRNAModerna, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.2K sh	—	—	0
2026-04-01	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.4K sh	—	—	20,400
2025-04-30	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,378 sh	—	—	6,378
2025-04-30	MRNAModerna, Inc. · Restricted Stock UnitsA Award	Director	AAward	+12.2K sh	—	—	12,174
2024-05-06	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,557 sh	—	—	7,557
2023-06-13	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,000
2023-05-03	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,134 sh	—	—	6,134
2022-07-25	TRMLTourmaline Bio, Inc.J Other	Director	JOther	−139K sh	—	—	0
2022-07-25	TRMLTourmaline Bio, Inc.J Other	Director	JOther	+139K sh	—	—	386,932
2022-07-25	TRMLTourmaline Bio, Inc.J Other	Director	JOther	−139K sh	—	—	0
2022-07-25	TRMLTourmaline Bio, Inc.J Other	Director	JOther	+139K sh	—	—	386,932
2022-07-21	TRMLTourmaline Bio, Inc.J Other	Director	JOther	−248K sh	—	—	87,735
2022-07-21	TRMLTourmaline Bio, Inc.J Other	Director	JOther	+248K sh	—	—	248,432
2022-07-21	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+36.5K sh	$3.72	+$136K	138,500
2022-07-21	TRMLTourmaline Bio, Inc.J Other	Director	JOther	−248K sh	—	—	147,255
2022-07-21	TRMLTourmaline Bio, Inc.J Other	Director	JOther	+248K sh	—	—	248,432
2022-07-21	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+36.5K sh	$3.72	+$136K	138,500
2022-07-20	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+52K sh	$3.62	+$188K	102,000
2022-07-20	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+52K sh	$3.62	+$188K	102,000
2022-07-19	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+50K sh	$3.52	+$176K	50,000
2022-07-19	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+50K sh	$3.52	+$176K	50,000
2022-06-09	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,501
2022-05-10	MRNAModerna, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+23.1K sh	$18.87	+$436K	23,803
2022-05-10	MRNAModerna, Inc.S Sale	Director	SSale	−3,196 sh	$136.10	−$435K	20,607
2022-05-10	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−23.1K sh	—	—	16,620
2022-04-28	MRNAModerna, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+703 sh	—	—	703
2022-04-28	MRNAModerna, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−703 sh	—	—	0
2022-04-28	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,415 sh	—	—	5,415
2021-12-15	TRMLTourmaline Bio, Inc.G Gift	Director	GGift	−59.5K sh	—	—	336,167
2021-11-19	ACCELERON PHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−6,749 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−576 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−8,185 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−3,222 sh	—	—	0
2021-07-21	ALEXION PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2021-05-20	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,962 sh	—	—	13,248
2021-05-20	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+673 sh	—	—	13,921
2021-04-28	MRNAModerna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,081 sh	—	—	4,081
2021-04-28	MRNAModerna, Inc. · Restricted Stock UnitsA Award	Director	AAward	+703 sh	—	—	703
2021-01-29	ACCELERON PHARMA INCA Award	Director	AAward	+1,622 sh	—	—	6,749
2021-01-29	ACCELERON PHARMA INCOption to Purchase Common StockA Award	Director	AAward	+3,222 sh	—	—	3,222
2021-01-22	Prevail Therapeutics Inc.U Disposition from Tender	Director	UDisposition from Tender	−23.7K sh	—	—	0

Recent filings

Accepted (ET)
May 84
Nader Francois0001682852-26-000088
SEC(opens sec.gov)
May 44
Nader Francois0001682852-26-000064
SEC(opens sec.gov)
Apr 34
Nader Francois0001365343-26-000003
SEC(opens sec.gov)
May 14
Nader Francois0001127602-25-012941
SEC(opens sec.gov)
May 74
Nader Francois0001127602-24-014472
SEC(opens sec.gov)
Jun 144
Nader Francois0001209191-23-037188
SEC(opens sec.gov)
May 54
Nader Francois0001127602-23-014680
SEC(opens sec.gov)
Sep 134/A
Nader Francois0000899243-22-030924
SEC(opens sec.gov)
Jul 254
Nader Francois0000899243-22-026684
SEC(opens sec.gov)

Companies

Address

C/O MODERNA, INC. 325 BINNEY STREET

CAMBRIDGE, MA, 02142